JNCCN 360 - Thyroid Cancer

Editor:

Robert I. Haddad, MD

Advertisement

Advertisement

Lori J. Wirth, MD, on RET-Altered Thyroid Cancer: Results From a Study on Selpercatinib

Enrique Grande, MD, PhD, on Targeted Treatment for Thyroid Cancer

Robert I. Haddad, MD, on Thyroid Cancer NCCN Clinical Practice Guidelines in Oncology®: Expert Perspective

Recent

Using Liquid Biopsy to Detect BRAF V600E in Papillary Thyroid Cancer

IGCS 2020: Thyroid Cancer and Pregnancy in Belarus

Rare Case of Lymph Node Metastasis of Papillary Thyroid Cancer to the Tongue

Radioactive Iodine Treatment After Thyroidectomy: Impact on Blood Cell Counts

Published

Medical Literature

South Korean Researchers Shed Light on Familial Nonmedullary Thyroid Cancer

Case Study: Link Between Hyperfunctioning Thyroid Nodule and Papillary Thyroid Carcinoma

Physician Survey Reveals Need for Clarity on Appropriate Use of Thyroid Ultrasonography

Vandetanib for Symptomatic and Progressive Medullary Thyroid Cancer

Ongoing

Differentiated thyroid cancer (DTC): therapeutic updates and optimizing treatment

A Unique Approach to Assessing the Risk of Indeterminate Thyroid Nodules

Current and Emerging Treatment Options for Lung Cancer and Head & Neck Carcinoma

Is Radioiodine Tx Overused in Low-Risk Thyroid Cancer?

Available

Clinical Trials

Stanford Cancer Institute

MD Anderson Cancer Center

Sarah Cannon Research Institute at HealthONE

Memorial Sloan Kettering Memorial Center

Advertisement

Advertisement

NCCN Resources

Copyright © 2020 National Comprehensive Cancer Network, All Rights Reserved

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.